Lv1
98 积分 2022-09-16 加入
Preservatives and ocular surface disease: A review
2天前
已完结
Drug Delivery Systems in Glaucoma- Current Innovations and Future Perspectives
3天前
已完结
Human experience and efficacy of omidenepag isopropyl (Eybelis®; Omlonti®): Discovery to approval of the novel non-prostaglandin EP2-receptor-selective agonist ocular hypotensive drug
3天前
已完结
Omidenepag Isopropyl Ophthalmic Solution 0.002%: First Global Approval
3天前
已完结
Quintessence of currently approved and upcoming treatments for dry eye disease
5天前
已完结
Developments in Emerging Topical Drug Delivery Systems for Ocular Disorders
5天前
已完结
From Vision Correction to Drug Delivery: Unraveling the Potential of Therapeutic Contact Lens
6天前
已完结
New treatments for glaucoma
7天前
已完结
The Impact of Aging on Ocular Diseases: Unveiling Complex Interactions
8天前
已完结
Update advances in anaplastic lymphoma kinase‐positive non–small cell lung cancer treatment
10天前
已关闭
皖公网安备34019202002308
